Profile
Annette Eschler worked as Head of Business Development at Acino International AG from 2008 to 2011.
Prior to that, she was Head of Portfolio Management at ratiopharm GmbH from 1996 to 2006 and Head of Business Development at Cimex AG from 2006 to 2008.
Eschler holds a doctorate degree from Universität Ulm.
Former positions of Annette Eschler
| Companies | Position | End |
|---|---|---|
| ACINO HOLDING AG | Corporate Officer/Principal | 31/03/2011 |
| Cimex AG | Corporate Officer/Principal | 31/12/2007 |
Ratiopharm GmbH
 Ratiopharm GmbH Pharmaceuticals: MajorHealth Technology ratiopharm GmbH engages in the production and distribution of generic drugs and pharmaceutical products. It offers pain relievers, nasal sprays, bronchial drops, as well as medicines for treating high blood pressure, cancer, pulmonary arterial hypertension, human immunodeficiency virus infection and acquired immune deficiency syndrome. The company was founded in 1973 and is headquartered in Ulm, Germany. | Corporate Officer/Principal | 31/12/2005 |
Training of Annette Eschler
| Universität Ulm | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Acino International AG
 Acino International AG Pharmaceuticals: MajorHealth Technology Acino International AG develops and manufactures pharmaceuticals in novel drug delivery form. The firm provides drug delivery technologies with a focus on modified release oral forms, oral dispersible forms, transdermal systems and extended release parenterals, for which it also holds patents. It offers abelcet, bactiflox, clopacin, dolonica, hydronica, neurorubine, olfen and spasfon. The company was founded in 1836 and is headquartered in Zurich, Switzerland. | Health Technology |
Ratiopharm GmbH
Ratiopharm GmbH Pharmaceuticals: MajorHealth Technology ratiopharm GmbH engages in the production and distribution of generic drugs and pharmaceutical products. It offers pain relievers, nasal sprays, bronchial drops, as well as medicines for treating high blood pressure, cancer, pulmonary arterial hypertension, human immunodeficiency virus infection and acquired immune deficiency syndrome. The company was founded in 1973 and is headquartered in Ulm, Germany. | Health Technology |
| Cimex AG |
- Stock Market
- Insiders
- Annette Eschler
